Limno Pharmaceuticals 

We develop new therapies for oftalmic and neurodegenerative diseases

OWNER

David Alcantara Parra (See Profile)

Sector

Therapeutics

Stage

Prototyping, preclinical

Country

Spain


IP protection secured at global level, 3 Proofs of concepts with animals (mice), Expected clinical trials in 15 months

Treatment of oftalmic diseases without intraocular injection of drugs, growing market CARG 5%

Several drugs in the pipeline, team with 60 years experience accumulated, Growing market globlally

This information is confidential, do not share or copy.

Under evaluation at least till: 30th of July

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

CONTACT US

Hi! Any doubts? Send us a message and we'll get back to you, asap.

Sending

©2018 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACCEPT
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar